Press Release

With an Estimated CAGR of 10.81%, Saudi Arabia Left Ventricular Assist Devices (LVADs) Market to Reach USD42.29 Million by 2030

The Saudi Arabia Left Ventricular Assist Devices (LVADs) Market size was valued at around USD21.92 million in 2024 and is projected to reach USD42.29 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.81% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report. This market shows excellent growth based on a couple of major factors. One among those is the increasing number of cases in Saudi Arabia suffering from heart failure. As per Saudi Heart Association in 2022, heart failure affects more than 1% of Saudi citizens with an estimated yearly incidence rate of more than 32,000 cases. The growing rates of heart failure have led to the use of more and more medical treatments, such as LVADs. Since they ensure that the heart pumps blood and continues all its functions, LVADs would be a lifesaver for most patients suffering from advanced stages of heart failure.

Increased demand for heart failure treatment within Saudi Arabia is fueling the growth of the market for LVADs due to the increasing number of Saudi Arabs who require their treatment. A National Library of Medicine conducted a survey in 2023, which indicated that there is still a lack of knowledge about heart failure with 13.8% of respondents knowing that they have a 20% chance of developing heart failure in their lifetime. They have a 20% chance of developing heart failure in their lifetime. The reported one-year readmission and post-discharge mortality rates were 7.4% and 7.3% respectively but very few people were aware of them. Female gender and lower education levels are linked to a lack of awareness.

The given results point towards the necessity for targeted education to improve the diagnosis, management, and results of heart failure patients. Thus, the importance of focused education for the betterment of diagnosis care and results for patients suffering from heart failure emerges from the given results. Subsequently, more people are going for treatments like LVADs and visiting medical practitioners. Indeed, in 2023 as per the World Health Organization, cardiovascular diseases are going to become more common in Saudi Arabia hence there is a dire need for more awareness, therapies, and advanced surgeries that include Left Ventricular Assist Devices, further states the research report “Saudi Arabia Left Ventricular Assist Devices (LVAD) Market Analysis, 2025”

Saudi Arabia Left Ventricular Assist Devices (LVADs) Market Segmentation Analysis

Non-Pulsatile Flow Type Captures the Largest Market Share  

Based on flow, the market is segmented into pulsatile flow and non-pulsatile flow. The non-Pulsatile flow leads the market with a market share of around 70%. Non-Pulsatile Flow LVADs are preferred over pulsatile flow devices due to their higher reliability, smaller size, and improved patient outcomes. Non-pulsatile flow ensures a steady flow of blood and an efficient circulatory mechanism that limits the occurrence of complications like device failure or blood clots and makes it a safer device for long-term usage. They are also less bulky, hence more convenient and portable to patients, especially those in continuous need of support. Increased demand for Non-Pulsatile Flow LVADs is also attributed to technological advancement that makes the device cheaper and more accessible. The constant stream of LVADs will probably keep on leading the market in Saudi Arabia and help patients achieve the most efficient and convenient treatment for managing heart failure.

Bridge to Transplantation Application is the Most Preferred in the Industry 

The bridge to transplantation BTT has the largest market share around 50%. It is used for patients with advanced heart failure and who are going for a heart transplant. LVADs in BTT applications provide vital short-term circulatory support to stabilize the patients until a suitable donor heart is available. As the shortage of donor organs grows and heart failure cases increase, BTT has become an essential solution for patients awaiting transplants.

In Saudi Arabia, heart transplant programs are now expanding and BTT is commonly used in top hospitals like King Faisal Specialist Hospital & Research Center which offers advanced cardiac care. Increasing heart failure rates are pushing the need for heart transplants up, thereby increasing the demand for BTT. This means that the BTT segment remains a critical component in the Saudi market, helping address the critical need for heart transplant support and improving patient outcomes.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including Abbott Laboratories, Medtronic PLC, Fresenius Medical Care AG & Co. KGaA, Abiomed Inc., Teleflex Incorporated, SynCardia Systems, CardiacAssist, Inc., Jarvik 2000, Reliant Heart, Edwards Lifesciences, GE Healthcare and Others are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the region?
4. How has the industry been evolving in terms of geography and product adoption?
5. How has the competition been shaping up across the region?
6. How have buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2020-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?